I don't believe there are thousands of drugs in FDA approved trials for Covid - maybe hundreds, and less than 500. Continuing to trial any drug is a burden on institutions and providers. It is also a burden on the patient, who is the focus of our care. I don't believe the FDA is as cavalier about this as you state. I agree with Skydive that the continued trial implies more than safety. It implies potential efficacy in the least. However thanks for acknowledging that leronlimab is safe!